XML 141 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
¥ in Millions, $ in Millions
12 Months Ended
Mar. 31, 2015
USD ($)
shares
Mar. 31, 2015
CNY (¥)
shares
Mar. 31, 2014
CNY (¥)
shares
Mar. 31, 2013
CNY (¥)
shares
Total Alibaba Group Holding Limited shareholders' equity (deficits) | IPO        
Increase (Decrease) in Stockholders' Equity        
Issuance of ordinary shares   ¥ 61,536    
Total Alibaba Group Holding Limited shareholders' equity (deficits)        
Increase (Decrease) in Stockholders' Equity        
Balance   29,338 ¥ (24) ¥ 31,488
Foreign currency translation adjustment   59 552 458
Net change in unrealized gains/ losses on available-for-sale investment securities   3,102 293 (9)
Change in fair value of interest rate swaps under hedge accounting   (36) 36  
Net income for the year   24,261 23,315 8,532
Liquidation and deconsolidation of subsidiaries     (14)  
Acquisition of shares of consolidated subsidiaries     (7) (13,105)
Disposals of partial interest in subsidiaries       1
Acquisition of subsidiaries   3,782 276 39
Issuance of ordinary shares       16,434
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans   676 688 394
Repurchase and retirement of ordinary shares   (256) (228) (45,218)
Deemed disposals of partial interest in subsidiaries arising from exercise or vesting of share-based awards   (7)    
Repurchase from, net of subscription, by noncontrolling interest for Partner Capital Investment Plan   (37)    
Redemption of treasury shares granted for Senior Management Share Incentive Scheme   15    
Amortization of compensation cost   12,659 2,784 1,090
Equity-settled donation     1,269  
Issuance of ordinary shares in relation to investment in equity investees and others     637  
Excess value receivable arising from the restructuring of the commercial arrangements with Ant Financial Services and related amortization   166    
Conversion of convertible preferred shares   10,293    
Accretion to convertible preferred shareholders   (15) (31) (17)
Dividend to convertible preferred shareholders   (97) (208) (111)
Balance   ¥ 145,439 ¥ 29,338 (24)
Ordinary Shares | Partner Capital Investment Plan        
Increase (Decrease) in Stockholders' Equity        
Issuance of ordinary shares (in shares) | shares     18,000,000  
Ordinary Shares | IPO        
Increase (Decrease) in Stockholders' Equity        
Issuance of ordinary shares (in shares) | shares 149,220,834 149,220,834    
Ordinary Shares        
Increase (Decrease) in Stockholders' Equity        
Balance   ¥ 1 ¥ 1 ¥ 1
Balance (in shares) | shares 2,226,810,660 2,226,810,660 2,175,220,739 2,506,952,201
Acquisition of shares of consolidated subsidiaries (in shares) | shares       1,446,505
Acquisition of subsidiaries (in shares) | shares 8,876,755 8,876,755 828,299  
Issuance of ordinary shares (in shares) | shares       167,741,936
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans (in shares) | shares 20,240,334 20,240,334 30,880,761 23,582,277
Repurchase and retirement of ordinary shares (in shares) | shares (892,859) (892,859) (3,943,139) (524,502,180)
Issuance of ordinary shares in relation to investment in equity investees and others (in shares) | shares     5,824,000  
Conversion of convertible preferred shares (In shares) | shares 91,243,312 91,243,312    
Balance   ¥ 1 ¥ 1 ¥ 1
Balance (in shares) | shares 2,495,499,036 2,495,499,036 2,226,810,660 2,175,220,739
Additional paid-in capital | IPO        
Increase (Decrease) in Stockholders' Equity        
Issuance of ordinary shares   ¥ 61,536    
Additional paid-in capital        
Increase (Decrease) in Stockholders' Equity        
Balance   27,043 ¥ 21,655 ¥ 20,778
Acquisition of shares of consolidated subsidiaries     (7) (13,105)
Disposals of partial interest in subsidiaries       1
Acquisition of subsidiaries   3,782 276 39
Issuance of ordinary shares       16,434
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans   516 700 469
Repurchase and retirement of ordinary shares   (13) (32) (3,923)
Deemed disposals of partial interest in subsidiaries arising from exercise or vesting of share-based awards   (7)    
Redemption of treasury shares granted for Senior Management Share Incentive Scheme   15    
Amortization of compensation cost   12,659 2,784 1,090
Equity-settled donation     1,269  
Issuance of ordinary shares in relation to investment in equity investees and others     637  
Excess value receivable arising from the restructuring of the commercial arrangements with Ant Financial Services and related amortization   1,318    
Conversion of convertible preferred shares   10,293    
Accretion to convertible preferred shareholders     (31) (17)
Dividend to convertible preferred shareholders     (208) (111)
Balance   117,142 27,043 21,655
Treasury shares        
Increase (Decrease) in Stockholders' Equity        
Balance   0 0  
Balance   0 0 0
Restructuring reserve        
Increase (Decrease) in Stockholders' Equity        
Excess value receivable arising from the restructuring of the commercial arrangements with Ant Financial Services and related amortization   (1,152)    
Balance   (1,152)    
Subscription receivables        
Increase (Decrease) in Stockholders' Equity        
Balance   (540) (852) (819)
Foreign currency translation adjustment     16 3
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans   160 (12) (75)
Repurchase and retirement of ordinary shares   6 308 39
Repurchase from, net of subscription, by noncontrolling interest for Partner Capital Investment Plan   (37)    
Balance   (411) (540) (852)
Statutory reserves        
Increase (Decrease) in Stockholders' Equity        
Balance   2,474 1,337 1,096
Liquidation and deconsolidation of subsidiaries   (26)    
Appropriation to statutory reserves   267 1,137 241
Balance   2,715 2,474 1,337
Cumulative translation adjustments        
Increase (Decrease) in Stockholders' Equity        
Balance   (1,144) (1,666) (2,121)
Foreign currency translation adjustment   49 536 455
Liquidation and deconsolidation of subsidiaries     (14)  
Balance   (1,095) (1,144) (1,666)
Unrealized gain (loss) on available-for-sale investment securities, interest rate swaps and others        
Increase (Decrease) in Stockholders' Equity        
Balance   321 (8) 1
Foreign currency translation adjustment   10    
Net change in unrealized gains/ losses on available-for-sale investment securities   3,102 293 (9)
Change in fair value of interest rate swaps under hedge accounting   (36) 36  
Balance   3,397 321 (8)
Retained earnings (Accumulated deficits)        
Increase (Decrease) in Stockholders' Equity        
Balance   1,183 (20,491) 12,552
Net income for the year   24,261 23,315 8,532
Liquidation and deconsolidation of subsidiaries   26    
Repurchase and retirement of ordinary shares   (249) (504) (41,334)
Accretion to convertible preferred shareholders   (15)    
Dividend to convertible preferred shareholders   (97)    
Appropriation to statutory reserves   (267) (1,137) (241)
Balance   24,842 1,183 (20,491)
Noncontrolling interest | Partner Capital Investment Plan        
Increase (Decrease) in Stockholders' Equity        
Issuance of ordinary shares     442  
Noncontrolling interest        
Increase (Decrease) in Stockholders' Equity        
Balance   1,079 537 2,895
Foreign currency translation adjustment   (7) 2  
Net income for the year   63 88 117
Liquidation and deconsolidation of subsidiaries   (378)   (60)
Acquisition of shares of consolidated subsidiaries     (2) (2,768)
Disposals of partial interest in subsidiaries       10
Acquisition of subsidiaries   10,897   294
Deemed disposals of partial interest in subsidiaries arising from exercise or vesting of share-based awards   17    
Repurchase from, net of subscription, by noncontrolling interest for Partner Capital Investment Plan   (86)    
Redemption of treasury shares granted for Senior Management Share Incentive Scheme   (15)    
Capital injection from noncontrolling interests   174    
Amortization of compensation cost   291 12 49
Dividend declared by a consolidated subsidiary to noncontrolling interests   (61)    
Balance   11,974 1,079 537
Partner Capital Investment Plan        
Increase (Decrease) in Stockholders' Equity        
Issuance of ordinary shares     442  
IPO        
Increase (Decrease) in Stockholders' Equity        
Issuance of ordinary shares   61,536    
Balance   ¥ 30,417 513 34,383
Balance (in shares) | shares 2,226,810,660 2,226,810,660    
Foreign currency translation adjustment   ¥ 52 554 458
Net change in unrealized gains/ losses on available-for-sale investment securities $ 500 3,102 293 (9)
Change in fair value of interest rate swaps under hedge accounting (6) (36) 36  
Net income for the year   24,324 23,403 8,649
Liquidation and deconsolidation of subsidiaries   (378) (14) (60)
Acquisition of shares of consolidated subsidiaries     (9) (15,873)
Disposals of partial interest in subsidiaries       11
Acquisition of subsidiaries   14,679 276 333
Issuance of ordinary shares       16,434
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans   676 688 394
Repurchase and retirement of ordinary shares   (256) (228) (45,218)
Deemed disposals of partial interest in subsidiaries arising from exercise or vesting of share-based awards   10    
Repurchase from, net of subscription, by noncontrolling interest for Partner Capital Investment Plan   (123)    
Capital injection from noncontrolling interests   174    
Amortization of compensation cost   12,950 2,796 1,139
Equity-settled donation     1,269  
Issuance of ordinary shares in relation to investment in equity investees and others     637  
Excess value receivable arising from the restructuring of the commercial arrangements with Ant Financial Services and related amortization   166    
Conversion of convertible preferred shares   10,293    
Accretion to convertible preferred shareholders   (15) (31) (17)
Dividend to convertible preferred shareholders   (97) (208) (111)
Dividend declared by a consolidated subsidiary to noncontrolling interests   (61)    
Balance $ 25,393 ¥ 157,413 ¥ 30,417 ¥ 513
Balance (in shares) | shares 2,495,499,036 2,495,499,036 2,226,810,660